Top Markets
Coin of the day
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
Rang in aandelen #3846
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Aandeelprijs
$79.97
Laatst gesynchroniseerd: 2025-02-19
Marktkapitalisatie
$4.57B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Inari Medical, Inc. (NARI)

Categorie

P/S-ratio voor Inari Medical, Inc. (NARI)
P/S-ratio op August 2026 TTM: 9.49
Volgens de meest recente financiële rapporten en aandelenkoers van Inari Medical, Inc. is de huidige P/S-ratio (TTM) 9.49. Eind 2022 had het bedrijf een P/S-ratio van 8.76.
P/S-ratiohistoriek voor Inari Medical, Inc. van 2018 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
2026 (TTM) 9.49 27.01%
2023 7.47 -14.75%
2022 8.76 -46.65%
2021 16.42 -18.01%
2020 20.02 -50.02%
2019 40.06 -85.68%
2018 279.83 0.00%
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
4.13 -56.44%
US
5.03 -46.95%
US
2.78 -70.65%
IE
3.67 -61.33%
US
- -
DE